Yulin Zhang
321 Zhongshan Rd
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer.
Journal: Cancer science
Published: September 19, 2024
A propensity-score-matched comparison of standard and extended pelvic lymph node dissection in robot-assisted laparoscopic radical cystectomy.
Journal: Journal of robotic surgery
Published: April 15, 2024
Patient-derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T-cell Recognition.
Journal: Angewandte Chemie (International ed. in English)
Published: November 19, 2023
ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape.
Journal: Cell death & disease
Published: August 31, 2023
Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer.
Journal: Gene
Published: April 20, 2023
The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.
Journal: Frontiers in immunology
Published: November 26, 2022
Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.
Journal: Heliyon
Published: May 22, 2022
Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
Journal: Frontiers in genetics
Published: April 14, 2022
Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer.
Journal: Frontiers in immunology
Published: April 02, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026